Tenet Healthcare is on the verge of a breakout, Strategas Research Partners Managing Director Chris Verrone said Thursday.
On CNBC's "Fast Money," Verrone said, "Favorite name right now, let's go to health care. Tenet, THC, about to get through $50. The target, $77, great base. It's done nothing for almost 15 years. The Street doesn't like it."
Verrone liked the sector, as well.
"Hospitals as a group look fantastic," he said. "Great group."